Timber Pharmaceuticals

Timber Pharmaceuticals is a company listed under the stock ticker TMBR (US).

View the org chart displaying its 8 main executives

Most searched biographies at Timber Pharmaceuticals

• John Koconis, Chief Executive Officer and Chairman of the Board
• Lubor Gaal, Director
• Edward Sitar, Director

Create your alert
to follow the executive moves at Timber Pharmaceuticals.

Timber Pharmaceuticals has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).
• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Timber Pharmaceuticals

Social media about Timber Pharmaceuticals

• Timber Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Timber Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including John Koconis

Call Timber Pharmaceuticals at +1 914...

View the org chart

Register to receive your alert

Report an error